Featured Research

from universities, journals, and other organizations

Sunlight Exposure Plus Low Antioxidant Levels May Place Older Adults At Risk For Eye Disease

Date:
October 19, 2008
Source:
London School of Hygiene & Tropical Medicine (LSHTM)
Summary:
People who lack essential antioxidants, and who have high levels of sunlight exposure, have a higher risk of developing advanced macular degeneration (AMD), according to a new study. AMD is a leading cause of poor vision.

People who lack essential antioxidants, and who have high levels of sunlight exposure, have a higher risk of developing advanced macular degeneration (AMD), according to a study published today in the journal Archives of Ophthalmology. AMD is the leading cause of poor vision in the UK.

The EUREYE study, led by Astrid Fletcher, Professor of Epidemiology of Ageing at the London School of Hygiene & Tropical Medicine, is the first to report in human populations an adverse association between sunlight exposure and AMD in people with low levels of antioxidants. It is also unprecedented in the level of detail the researchers used, taking into account not only lifestyle and medical factors but even going so far as to estimate levels of cloud cover in each of the countries from which participants were recruited.

The eye is particularly vulnerable to the damaging effects of sunlight. Ultraviolet radiation is absorbed by the lens, but visible or “blue” light penetrates to the retina so allowing us to see. Protection against the harmful effects of blue light is provided by the antioxidant vitamins C and E, the carotenoids (lutein and zeaxanthin) which filter blue light, and zinc.

Animal and laboratory studies have previously shown that blue light may be a factor in the pathogenesis of AMD, but results have been inconsistent in the few studies that have investigated associations between sunlight exposure and AMD in human populations. Little attention has been paid to the possible interactions between antioxidant levels and light exposure, although it is thought that the adverse effects of sunlight may be mitigated by the protective effects of antioxidants.

4,753 participants aged 65 years were selected randomly in seven centres, Bergen in Norway, Tallinn in Estonia, Belfast in the UK, Paris-Creteil in France, Verona in Italy, Thessaloniki in Greece and Alicante in Spain. The average age of participants was 73.2 and 55% were women. Blue light exposures tended to be higher in participants from centres in southern Europe while participants in an exclusively urban centre (Paris) had the lowest exposures.

Participants underwent fundus photography, and gave a blood sample for antioxidant analysis. They completed a residence and job history in advance, and attended a face-to-face interview. They were asked about their education, smoking and alcohol use, medical history, lifetime residence and level of sunlight exposure, including how much time they had spent outdoors between the hours of 9am and 5pm, and 11am and 3pm each day since they left school and throughout their working life.

Information was collected separately for summer and winter, and for different occupational time periods (including time spent looking after the home) and in retirement up to their current age. For each period, they were asked about their use of eyewear (glasses, contact lenses and sunglasses). The information on sunlight exposure and area of residence was sent to the University of East Anglia and combined with metrological information to estimate lifetime blue light exposure for each participant.

The results indicated that those with the lowest levels of antioxidants were most at risk of AMD due to blue light. In particular, the combination of blue light exposure and low levels of zeaxanthin, alpha tocopherol and Vitamin C was associated with a nearly four-fold likelihood of developing AMD. The researchers found that the associations of blue light in those with low antioxidant status appeared stronger at older ages, reaching a peak at 50-59 years.

The combination of blue light exposure and low concentrations of antioxidants in the blood was also found to be associated with the early stages of AMD, which are common in the population, and that exposures in middle age might be more damaging than at younger ages.

Professor Fletcher comments: ‘In the absence of cost-effective screening methods to identify people in the population with early AMD, we suggest that recommendations on protecting the eyes, ensuring that diets contain the right nutrients and antioxidants, are targeted at the general population, and especially middle-aged people’.

‘We are not telling people to stay out of the sun altogether. The benefits of sunlight are well documented, in particular its role in vitamin D synthesis. But if people want to avoid macular degeneration as they get older, they should avoid exposing their eyes to too much sunlight when they are outside, and take simple precautions, such as wearing a wide-brimmed hat and sunglasses.

‘Nor are we recommending that people should take vitamin supplements. It is perfectly possible to achieve the recommended dietary reference intakes for these essential antioxidants by following a balanced diet’.


Story Source:

The above story is based on materials provided by London School of Hygiene & Tropical Medicine (LSHTM). Note: Materials may be edited for content and length.


Journal Reference:

  1. Fletcher et al. Sunlight Exposure, Antioxidants, and Age-Related Macular Degeneration. Archives of Ophthalmology, 2008; 126 (10): 1396 DOI: 10.1001/archopht.126.10.1396

Cite This Page:

London School of Hygiene & Tropical Medicine (LSHTM). "Sunlight Exposure Plus Low Antioxidant Levels May Place Older Adults At Risk For Eye Disease." ScienceDaily. ScienceDaily, 19 October 2008. <www.sciencedaily.com/releases/2008/10/081013171431.htm>.
London School of Hygiene & Tropical Medicine (LSHTM). (2008, October 19). Sunlight Exposure Plus Low Antioxidant Levels May Place Older Adults At Risk For Eye Disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/10/081013171431.htm
London School of Hygiene & Tropical Medicine (LSHTM). "Sunlight Exposure Plus Low Antioxidant Levels May Place Older Adults At Risk For Eye Disease." ScienceDaily. www.sciencedaily.com/releases/2008/10/081013171431.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins